Lifeboat Foundation

Few cases and no deaths. I would listen to those who have success, not those who have failure. Scientists from failing countries have warned not to take just about everything to fight this. The WHO’s abysimal performance shows they are the last people anyone should listen to. Show the efficacy of WHO advice, or even ventilators for that matter vs Continuous Positive Airway Pressure (CPAP). If people want to use something to fight this let them, you have the choice of not using it.

Madagascar’s President Andry Rajoelina tries Covid-Organics at a launch ceremony in Antananarivo on 20 April. Several other African leaders have expressed an interest in the unproven treatment.

Diagnosing COVID-19 more quickly, easily, and broadly

With COVID-19 rapidly spreading around the planet, the efficient detection of the CoV2 virus is pivotal to isolate infected individuals as early as possible, support them in whatever way possible, and thus prevent the further uncontrolled spread of the disease. Currently, the most-performed tests are detecting snippets of the virus’ genetic material, its RNA, by amplifying them with a technique known as “polymerase chain reaction” (PCR) from nasopharyngeal swabs taken from individuals’ noses and throats.

The tests, however, have severe limitations that stand in the way of effectively deciding whether people in the wider communities are infected or not. Although PCR-based tests can detect the virus’s RNA early on in the disease, test kits are only available for a fraction of people that need to be tested, and they require trained health care workers, specialized laboratory equipment, and significant time to be performed. In addition, health care workers that are carrying out testing are especially prone to being infected by CoV2. To shorten patient-specific and community-wide response times, Wyss Institute researchers are taking different parallel approaches:

No se aceptan los comentarios con contenidos, enlaces o nombres de usuarios que se consideren insultantes. –No se aceptan los comentarios que apoyen violaciones de los derechos humanos. –No se admitirán los ataques ni insultos a los otros participantes en el sistema de comentarios. –No se admiten comentarios con contenidos o enlaces que se consideren publicidad, spam, pornografía o material protegido por derechos de autor. –Los comentarios sin sentido o repetidos serán eliminados. –Medicina21 se reserva el derecho a eliminar los comentarios que no se ajusten a estas normas.

In 2015, Elon Musk announced that his company, SpaceX, would be deploying satellites to orbit that would provide high-speed broadband internet access to the entire world. Known as Starlink, SpaceX began deploying this constellation in May of 2019 with the launch of the first 60 satellites. As of April 22, a total of 422 satellites have been added to the Starlink constellation, and the response hasn’t been entirely positive.

In addition to fears that we’re adding to the problem of “space junk,” there are also those who’ve expressed concern that Starlink and other constellations could have a negative impact on astronomy. In response, SpaceX recently announced that it will be instituting changes in how the satellites are launched, how they orbit the Earth, and even how reflective they are in order to minimize the impact they have on astronomy.

These changes were the subject of a presentation made during the Decadal Survey on Astronomy and Astrophysics 2020 (Astro2020) hosted by the National Academy of Sciences, Engineering, and Medicine. As part of the Optical Interference from Satellite Constellations Meeting held on Monday, April 27th, the Starlink Panel (which included Musk) presented how the company hopes to minimize light pollution caused by their constellation.

A team of materials scientists at Lawrence Berkeley National Laboratory (Berkeley Lab) – scientists who normally spend their time researching things like high-performance materials for thermoelectrics or battery cathodes – have built a text-mining tool in record time to help the global scientific community synthesize the mountain of scientific literature on COVID-19 being generated every day.

The tool, live at covidscholar.org, uses natural language processing techniques to not only quickly scan and search tens of thousands of research papers, but also help draw insights and connections that may otherwise not be apparent. The hope is that the tool could eventually enable “automated science.”

“On Google and other search engines people search for what they think is relevant,” said Berkeley Lab scientist Gerbrand Ceder, one of the project leads. “Our objective is to do information extraction so that people can find nonobvious information and relationships. That’s the whole idea of machine learning and natural language processing that will be applied on these datasets.”

Circa 2013

“Nanotechnology offers unprecedented possibilities for progress—defeating poverty, starvation, and disease, opening up outer space, and expanding human capacities. But it also brings unprecedented risks—the specter of devastating wars fought with far more powerful weapons of mass destruction.” — Chris Phoenix, Director of Research, Center for Responsible Nanotechnology.

A University of Saskatchewan (USask) research team has uncovered how bats can carry the Middle East respiratory syndrome (MERS) coronavirus without getting sick—research that could shed light on how coronaviruses make the jump to humans and other animals.

Coronaviruses such as MERS, Severe Acute Respiratory Syndrome (SARS), and more recently the COVID19-causing SARS-CoV-2 virus, are thought to have originated in bats. While these viruses can cause serious and often fatal disease in people, for reasons not previously well understood, bats seem unharmed.

“The bats don’t get rid of the virus and yet don’t get sick. We wanted to understand why the MERS virus doesn’t shut down the bat immune responses as it does in humans,” said USask microbiologist Vikram Misra.

He continued, “This is a surprise: Overwhelmingly, the people were at home. We thought maybe they were taking public transportation, and we’ve taken special precautions on public transportation, but actually no, because these people were literally at home.”

“They’re not working. They’re not traveling,” Cuomo added, according to NBC News. “We were thinking that maybe we were going to find a higher percent of essential employees who were getting sick because they were going to work — that these may be nurses, doctors, transit workers. That’s not the case. They were predominantly at home.”

Medical researchers in the Republic of the Congo have discovered that an Israeli-developed HIV drug apparently can be used to successfully treat critically ill COVID-19 patients. Furthermore, the drug might be available within “weeks to months, but not more” after further clinical trials are carried out.

Doctors from the Clinique La Source hospital in the Congolese capital Brazzaville noted that HIV patients who were in critical condition due to COVID-19 showed significant improvement after being administered a drug named Gammora for their HIV symptoms.

Local researchers in Republic of the Congo note improvement among HIV patients with COVID-19, conduct small trial that confirms outcome.

Continue reading “Israeli HIV drug successfully treats coronavirus patients in Congo” »